Can I take two 120 mg extended‑release tablets instead of one 240 mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can You Take Two 120 mg Extended-Release Tablets Instead of One 240 mg Tablet?

Yes, taking two 120 mg extended-release tablets is generally equivalent to one 240 mg tablet for most calcium channel blockers (diltiazem and verapamil), as the total daily dose remains the same and bioavailability is preserved.

Evidence-Based Rationale

The 2016 ESC Guidelines for atrial fibrillation management specify that diltiazem can be dosed as "120–360 mg once daily modified release" for long-term oral rate control 1. This dosing flexibility inherently supports that the total daily dose matters more than the specific tablet configuration, as long as the extended-release properties are maintained.

Pharmacokinetic Evidence

Research directly addressing this question demonstrates:

  • For verapamil: A crossover study in healthy volunteers showed that two 120 mg sustained-release tablets produced no significant differences in Cmax, Tmax, or area under the curve compared to one 240 mg tablet 2. The mean bioavailability was 107% (95% CI: 81-142%), confirming equivalent drug exposure.

  • For diltiazem: Clinical trials in hemodialysis patients with coronary artery disease found that 120 mg twice daily sustained-release formulation was as effective as four 60 mg tablets for reducing myocardial ischemia, with improved safety during dialysis 3.

Important Clinical Considerations

When This Substitution Works

  • Extended-release formulations only: The substitution is appropriate when both the 120 mg and 240 mg versions are extended-release preparations
  • Same manufacturer preferred: Stick with the same brand/formulation to ensure consistent release characteristics
  • Swallow whole: Both tablets must be swallowed intact—do not split, crush, or chew extended-release tablets 4, 5

Critical Warnings About Tablet Splitting

Never split a 240 mg extended-release tablet in half to create two "120 mg" doses. This practice:

  • Destroys the extended-release mechanism
  • Can cause uncontrolled rapid drug release leading to hypotension, bradycardia, and heart block 4
  • Results in unpredictable dosing despite one study suggesting verapamil SR retains some properties when broken 2—this finding should not guide clinical practice for safety reasons

Dosing Schedule Matters

The 2014 AHA/ACC/HRS guidelines specify that diltiazem extended-release is dosed "120–360 mg QD (ER)" 6. If you're taking two 120 mg tablets:

  • Take them together once daily (not split into twice-daily dosing)
  • This maintains the once-daily convenience of extended-release formulations
  • One study showed twice-daily dosing of 120 mg was more effective than 240 mg once daily for blood pressure control 7, but this contradicts standard extended-release prescribing and may reflect older formulation technology

Practical Algorithm

Step 1: Verify both tablets are extended-release formulations

  • If yes → proceed to Step 2
  • If no → consult prescriber; immediate-release requires different dosing

Step 2: Confirm same manufacturer/brand

  • If yes → substitution is appropriate
  • If no → check with pharmacist about formulation equivalence

Step 3: Take both 120 mg tablets together once daily

  • Do not split the dosing
  • Swallow tablets whole with food (calcium channel blockers are typically taken with meals)

Step 4: Monitor for effectiveness and side effects

  • Watch for dizziness, peripheral edema, headache 1
  • Check heart rate and blood pressure regularly
  • Report excessive bradycardia (<50 bpm) or hypotension

Common Pitfalls to Avoid

  1. Don't assume all extended-release formulations are identical: Different manufacturers may have varying release profiles
  2. Don't split extended-release tablets: This is the most dangerous error—it converts a controlled-release medication into immediate-release with potential for toxicity
  3. Don't switch between once-daily and twice-daily dosing arbitrarily: Stick with the prescribed schedule
  4. Avoid in decompensated heart failure: Calcium channel blockers are contraindicated with LVEF <40% 1, 6

The substitution of two 120 mg extended-release tablets for one 240 mg tablet is pharmacologically sound and clinically acceptable, provided you maintain the extended-release properties by swallowing tablets whole and follow the once-daily dosing schedule.

References

4
Research

[Tablet splitting].

Therapeutische Umschau. Revue therapeutique, 2006

Related Questions

Is the medication available as a 4 mg tablet?
Should a 1.1 cm ovarian follicle be followed up with repeat ultrasound?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
How should a 10-year-old boy with two episodes of diarrhea, mild abdominal pain, and no fever be managed?
Can I increase the oral diltiazem dose for atrial fibrillation?
What patient education should be provided for hydroxyurea therapy in sickle cell disease, including dosing, administration, monitoring, side effects, and safety precautions?
What differential diagnoses and workup should be considered for a patient with hemoglobin 11 g/dL, low mean corpuscular hemoglobin (MCH) 25.5 pg, and low mean corpuscular hemoglobin concentration (MCHC) 30.1 g/dL?
Is there a sensory intercostal nerve along the inferior margin of the left ribs?
What are the indications, insertion technique, maintenance, and removal recommendations for an indwelling (Foley) urinary catheter?
Given a fasting glucose of 111 mg/dL, HbA1c 5.9%, triglycerides 157 mg/dL, and HDL cholesterol 31 mg/dL (with otherwise normal comprehensive metabolic panel and lipid profile), what lifestyle and pharmacologic interventions should be recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.